Novo’s Wegovy and Ozempic are among the most closely watched new medications in recent history, but face serious competition ...

--"The 2025 forecast will command the most attention in the annual accounts," Hansen said. "The addition of production capacity will continue to be the guiding principle for the full-year forecast." ...

A new analysis from the Danish think Tank CONCITO says that Denmark has only a 20% chance of meeting its 2030 climate goal under current policies. The report highlights risks in key areas such as ...

Novo’s record profit from obesity drugs has given the Foundation a war chest to fund its philanthropic grants, although ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Novo Nordisk. If we consider the specifics of ...

The Novo Nordisk Foundation does not plan to step in to prop up a global health sector reeling from a freeze on U.S.-funded ...

In a Fox News interview, U.S. Vice President J.D. Vance criticized Denmark’s handling of Greenland, stating, “Denmark, which controls Greenland, is not doing its job. And that is not a good ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

Learn more about whether AbbVie Inc. or Genmab A/S is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Luckily, the hiring process proceeded smoothly and Charles van Zyl joined as chief executive from Belgian pharma company UCB ...

I’m not going to report record revenue, but it was nonetheless a robust year," CEO Bernard Arnault said during the earnings ...